Cargando…

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis

OBJECTIVE: Clostridioides difficile infection (CDI) is a common healthcare-associated infection and associated with high morbidity and mortality. As current guidelines recommend treatment stratified for disease severity, this study aimed to identify predictors of 30-day mortality in order to develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katzer, Katrin Claudia, Hagel, Stefan, Reuken, Philipp Alexander, Bruns, Tony, Stallmach, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484870/ https://www.ncbi.nlm.nih.gov/pubmed/32912845 http://dx.doi.org/10.1136/bmjgast-2020-000468

Ejemplares similares

Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates
por: Pensinger, Daniel A., et al.
Publicado: (2023)

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
por: Wiese, Maria, et al.
Publicado: (2022)

Sleeping with the enemy: Clostridium difficile infection in the intensive care unit
por: Prechter, Florian, et al.
Publicado: (2017)

Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile
por: Yang, Jingpeng, et al.
Publicado: (2019)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization
por: Scaria, Elizabeth, et al.
Publicado: (2020)

Electrical Impedance Tomography (EIT) in a Patient Suffering from Post-COVID Syndrome with Dyspnea: A Case Report
por: Katzer, Katrin, et al.
Publicado: (2022)

An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
por: Gu, Ting, et al.
Publicado: (2022)

Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
por: Horn, Paul, et al.
Publicado: (2018)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Trends in the epidemiology of Clostridioides difficile infection in Germany
por: Vehreschild, Maria Johanna Gobertina Tetuanui, et al.
Publicado: (2023)

Gut Microbiota Diversity of Preterm Neonates Is Associated With Clostridioides Difficile Colonization
por: Couturier, Jeanne, et al.
Publicado: (2022)

The impact of dietary fibers on Clostridioides difficile infection in a mouse model
por: Wu, Zhengjie, et al.
Publicado: (2022)

Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography
por: Gremme, Yvonne, et al.
Publicado: (2023)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection
por: Madden, Gregory R., et al.
Publicado: (2023)

Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile
por: Seth-Smith, Helena M. B., et al.
Publicado: (2021)

Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Clostridioides difficile infection: curbing a difficult menace
por: Khanna, Sahil, et al.
Publicado: (2022)

Immune response against Clostridioides difficile and translation to therapy
por: Sehgal, Kanika, et al.
Publicado: (2021)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021)

The interplay of Clostridioides difficile infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile Infections in Germany, 2010–2019: A Review from Four Public Databases
por: Brestrich, Gordon, et al.
Publicado: (2023)

Incidence, predictors, and 30-day outcomes of Clostridioides difficile infection in patients undergoing cystectomy: A national database analysis
por: Mansoor, Armaghan-e-Rehman, et al.
Publicado: (2023)

High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2021)

Application of a core genome sequence typing (cgMLST) pipeline for surveillance of Clostridioides difficile in China
por: Wang, Yuan Yuan, et al.
Publicado: (2023)

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)

Transitions of care in Clostridioides difficile infection: a need of the hour
por: Khanna, Sahil, et al.
Publicado: (2022)

The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

In vitro models to study Clostridioides difficile infection: current systems and future advances
por: Ewin, Duncan, et al.
Publicado: (2023)

Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

Low-toxin Clostridioides difficile RT027 strains exhibit robust virulence
por: Anwar, Farhan, et al.
Publicado: (2022)

High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Clostridioides Difficile Infection
por: Lee, Sang Hoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_38i4qlaqmupjmhukd26akllo5v